Close menu

October 28th, 2021 | 13:20 CEST

BASF, Memiontec, JinkoSolar: Rich returns with green shares

  • Investments
Photo credits:

Chemistry is everything. It is not just since the bestseller "Chemistry for Breakfast" by scientist and YouTuber Mai Thi Nguyen-Kim that people have known how comprehensively chemistry can explain our world. There is also a lot of chemistry involved in future technology, such as filter systems for water or solar panels. We present three stocks and assess their values. We start with one of the best-known chemical stocks, followed by smaller shares with no less interesting business models.

time to read: 3 minutes | Author: Nico Popp
ISIN: BASF SE NA O.N. | DE000BASF111 , Memiontec Holdings Limited | SGXE56008290 , JINKOSOLAR ADR/4 DL-00002 | US47759T1007

Table of contents:

    BASF: Rising forecasts, dull share price

    BASF started the year somewhat conservatively and kept spectacular forecasts under wraps. But the market did not trust the conservative people at BASF and sent the share significantly upward as early as last fall. By the end of the first quarter of 2021, the share had posted a return of almost 50% - and rightly so, as it turned out in retrospect. For the third time in a row, the chemical giant from Ludwigshafen raised its forecast. In 2021, BASF now expects sales of between EUR 76 billion and EUR 78 billion, with profit before special items expected to be between EUR 7.5 billion and EUR 8 billion.

    BASF also continues to expect good business in basic chemicals and also plastics. Elsewhere, the Company is warning of the consequences of supply bottlenecks. These concerns are also likely to paralyze the share price at present. Despite the triple forecast increase and a now handsome dividend of around 5%, the share price is not getting off the ground. BASF has a low valuation but is still not picking up speed. The catalysts are missing here. But then the share could become an excellent stock in the long term.

    Memiontec: Clean water for Asia - the insider tip

    The share of Memiontec has already jumped this year. The specialist for water treatment in Asia offers complete solutions for water management. In addition to clean water, this also involves wastewater. Specifically, Memiontec operates in Singapore, China and Indonesia, covering three exciting markets. Population growth in Asia and the trend towards urbanization are placing increasing demands on drinking water. Due to Memiontec's more than 20 years of experience in the field of water treatment and also in cooperation with local authorities, the Company can benefit from the major trends in Asia.

    Specifically, Memiontec earns money on the one hand from the sale of purified water and, on the other hand, through service and operating services related to water infrastructure. Since water supply contracts are usually very long-term - terms of up to 25 years are not uncommon but rather the rule - Memiontec secures regular earnings. The Memiontec share is, therefore, an exciting infrastructure investment in Asia. After the rise of the share in the summer, the value has been very stable so far. This relative strength could prepare the ground for further increases. Although Memiontec is a niche investment, the outlook in Asia around solutions for water management is promising.

    JinkoSolar: Energy shortage as share price driver

    JinkoSolar's solutions are also considered promising. The Company is a global leader in solar modules and scores both with its modules' performance and durability. In this position, investors also like to buy JinkoSolar. Recently, the share was the plaything of two developments in China: First, the value suffered a little from the China fear, which was rampant around interventions of the central government and also because of the difficulties of the real estate company China Evergrande. But then the energy shortage dominated the front pages: Chinese industrial companies sometimes even have to stop the assembly lines, which does not exactly help the stuttering supply chains. In response, China is looking to expand renewable energy. This news brought the share of JinkoSolar the liberation blow - on a one-month view, the value climbed by about 28%.

    In the long term, however, the latest development is at best a flash in the pan - only at prices above the EUR 52.50 mark in German trading will the stock enter friendly waters again for the long term. However, the share is a good choice when it comes to investing in renewable energy. As a world-class manufacturer, JinkoSolar should be one of the big beneficiaries of climate change.

    While the JinkoSolar share has already gained around 600% over three years, Memiontec has not yet experienced such a spectacular development. However, the rise in the summer of this year should have attracted the attention of investors. If the value continues to consolidate at this level, the share could soon provide renewed impetus. However, the share remains speculative. BASF, on the other hand, is a safe bet, although it currently lacks the momentum for a further increase.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by André Will-Laudien on May 10th, 2022 | 11:54 CEST

    GreenTech stocks are on the rise! Buy now: BASF, Meta Materials, Nordex, Siemens Energy

    • GreenTech
    • Technology
    • Investments

    The distortions on the capital markets can hardly be topped at the moment. The nickel price has risen by 300%, only to drop by 70% again. And all this in only 48 hours. There are countless examples in the current stock market environment that are historically unparalleled. In just 2 months, the Bund Future fell from 178 to 151, a loss of 16% in the 10-year Bund. In parallel, the capital market interest rate rose from minus 0.45% to a whopping plus 1.15%. So interest rates are back, inflation is spreading, and supply deficits continue to fuel the underlying stagflation scenario! One major trend should bounce back after the end of the many corrections: GreenTech! Here is a selection of interesting stocks.


    Commented by Carsten Mainitz on May 10th, 2022 | 10:39 CEST

    Zalando, Aspermont, SAP - Corona and back, the stock rebound is coming!

    • Digitization
    • Investments
    • Technology

    What would society and the economy look like without digitization? The Internet, software and smartphones have become a matter of everyday life and form the basis for communication and interaction. Corona has been an accelerator in many ways. On the other hand, pandemics and war clearly show us the limits of supposedly predictable growth with scarcity prices and supply chain disruptions. At a reduced price level, it is worth looking at "digitization stocks" that offer good opportunities.


    Commented by Juliane Zielonka on May 5th, 2022 | 12:57 CEST

    Bayer, NervGen, Adler Group - Pharma and Real Estate, management in focus

    • Biotechnology
    • Pharma
    • Investments

    Corporate giant Bayer is collaborating with Charité Berlin to cure genetic diseases in the future. A paradox? Big Pharma thrives on alleviating symptoms but not curing diseases. Things will soon look different. The biotech company NervGen is also dedicated to curing diseases. The approach here: reverse degenerative nerve conditions through self-healing. Specifically, this means helping individuals with paraplegia who are wheelchair-bound reconnect their neural pathways. The Company is in the clinical trials phase and was started by a co-founder who witnessed a dramatic accident. One cannot speak of an accident at the real estate company Adler Group. Four board members have resigned after auditor KPMG refused to give its OK for the annual financial statements. Can management regain the confidence of shareholders?